Vesper Bio awarded grant to assess sortilin inhibitors to treat Parkinson’s disease
Vesper Bio has been awarded a grant worth $873,000 by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to assess sortilin inhibition in Parkinson’s disease